1. Home
  2. NEO vs BLMN Comparison

NEO vs BLMN Comparison

Compare NEO & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • BLMN
  • Stock Information
  • Founded
  • NEO 2001
  • BLMN 1988
  • Country
  • NEO United States
  • BLMN United States
  • Employees
  • NEO N/A
  • BLMN N/A
  • Industry
  • NEO Precision Instruments
  • BLMN Restaurants
  • Sector
  • NEO Health Care
  • BLMN Consumer Discretionary
  • Exchange
  • NEO Nasdaq
  • BLMN Nasdaq
  • Market Cap
  • NEO 902.1M
  • BLMN 736.6M
  • IPO Year
  • NEO 1999
  • BLMN 2012
  • Fundamental
  • Price
  • NEO $7.53
  • BLMN $10.16
  • Analyst Decision
  • NEO Buy
  • BLMN Hold
  • Analyst Count
  • NEO 9
  • BLMN 11
  • Target Price
  • NEO $13.31
  • BLMN $13.35
  • AVG Volume (30 Days)
  • NEO 2.2M
  • BLMN 2.7M
  • Earning Date
  • NEO 07-29-2025
  • BLMN 08-05-2025
  • Dividend Yield
  • NEO N/A
  • BLMN 5.91%
  • EPS Growth
  • NEO N/A
  • BLMN N/A
  • EPS
  • NEO N/A
  • BLMN N/A
  • Revenue
  • NEO $672,361,000.00
  • BLMN $3,930,996,000.00
  • Revenue This Year
  • NEO $13.97
  • BLMN $1.28
  • Revenue Next Year
  • NEO $11.36
  • BLMN $1.55
  • P/E Ratio
  • NEO N/A
  • BLMN $11.24
  • Revenue Growth
  • NEO 10.10
  • BLMN N/A
  • 52 Week Low
  • NEO $6.08
  • BLMN $6.09
  • 52 Week High
  • NEO $19.12
  • BLMN $21.45
  • Technical
  • Relative Strength Index (RSI)
  • NEO 52.96
  • BLMN 65.99
  • Support Level
  • NEO $7.04
  • BLMN $8.47
  • Resistance Level
  • NEO $7.73
  • BLMN $9.08
  • Average True Range (ATR)
  • NEO 0.35
  • BLMN 0.62
  • MACD
  • NEO 0.08
  • BLMN 0.12
  • Stochastic Oscillator
  • NEO 79.78
  • BLMN 96.06

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: